Peter Jönsson

Peter Jönsson currently serves as the Clinical Development Medical Director at Camurus since February 2024. With extensive experience in the pharmaceutical industry, Peter Jönsson has held leadership roles at LEO Pharma since September 2017, including Senior Medical Director and Medical Director, focusing on developing a novel compound in dermatology. Prior roles include Medical Advisor at Novartis, responsible for the respiratory franchise, and International Medical Director at Novo Nordisk, overseeing the development of a novel FVIII compound for hemophilia A. Early career experience includes positions at AstraZeneca and Ferring Pharmaceuticals in various clinical and pharmacology roles. Peter Jönsson holds a PhD in Pharmacokinetics and an MD from Lund University, a Diploma in Managing Medicinal Product Innovation from Copenhagen Business School, and a Diploma of Education in Pharmaceutical Medicine from Karolinska Institutet.